Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Virol ; 75(16): 7453-61, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11462017

RESUMEN

Mouse mammary tumor virus (MMTV) is a retrovirus encoding a superantigen that is recognized in association with major histocompatibility complex class II by the variable region of the beta chain (V(beta)) of the T-cell receptor. The C-terminal 30 to 40 amino acids of the superantigen of different MMTVs display high sequence variability that correlates with the recognition of particular T-cell receptor V(beta) chains. Interestingly, MMTV(SIM) and mtv-8 superantigens are highly homologous but have nonoverlapping T-cell receptor V(beta) specificities. To determine the importance of these few differences for specific V(beta) interaction, we studied superantigen responses in mice to chimeric and mutant MMTV(SIM) and mtv-8 superantigens expressed by recombinant vaccinia viruses. We show that only a few changes (two to six residues) within the C terminus are necessary to modify superantigen recognition by specific V(beta)s. Thus, the introduction of the MMTV(SIM) residues 314-315 into the mtv-8 superantigen greatly decreased its V(beta)12 reactivity without gain of MMTV(SIM)-specific function. The introduction of MMTV(SIM)-specific residues 289 to 295, however, induced a recognition pattern that was a mixture of MMTV(SIM)- and mtv-8-specific V(beta) reactivities: both weak MMTV(SIM)-specific V(beta)4 and full mtv-8-specific V(beta)11 recognition were observed while V(beta)12 interaction was lost. The combination of the two MMTV(SIM)-specific regions in the mtv-8 superantigen established normal MMTV(SIM)-specific V(beta)4 reactivity and completely abolished mtv-8-specific V(beta)5, -11, and -12 interactions. These new functional superantigens with mixed V(beta) recognition patterns allowed us to precisely delineate sites relevant for molecular interactions between the SIM or mtv-8 superantigen and the T-cell receptor V(beta) domain within the 30 C-terminal residues of the viral superantigen.


Asunto(s)
Virus del Tumor Mamario del Ratón/inmunología , Receptores de Antígenos de Linfocitos T alfa-beta/inmunología , Superantígenos/inmunología , Linfocitos T/inmunología , Secuencia de Aminoácidos , Aminoácidos , Animales , Presentación de Antígeno , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Receptores de Antígenos de Linfocitos T alfa-beta/genética , Alineación de Secuencia , Superantígenos/genética
2.
Virology ; 193(1): 385-95, 1993 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8382402

RESUMEN

We have recently described Avian Leukosis Virus (ALV)-based packaging cell lines that can produce helper-free ALV-based retrovirus vectors with A, B, C, and E envelope host ranges. Here, we report that lacZ retroviral vectors of subgroup C or E can infect helper cells of subgroup A (Isolde) which are then able to produce high titers of lacZ recombinant viruses of subgroup A. Superinfection of helper cells by lacZ recombinant virus was performed by cocultivating packaging cells with two subgroup specificities (A and E), but this did not result in increased recombinant virus titers. This "ping-pong" process caused the emergence of replication-competent (RC) viruses which are shown to result from recombination between the viral sequences of the helper cell lines and the cis-acting sequences of the lacZ recombinant virus.


Asunto(s)
Línea Celular/microbiología , Vectores Genéticos/fisiología , Retroviridae/crecimiento & desarrollo , Linfocitos T Colaboradores-Inductores/microbiología , Virus de la Leucosis Aviar/genética , Virus de la Leucosis Aviar/crecimiento & desarrollo , Secuencia de Bases , ADN Viral/genética , Vectores Genéticos/genética , Operón Lac , Datos de Secuencia Molecular , Recombinación Genética , Retroviridae/genética , Transfección , Replicación Viral
3.
J Virol ; 66(9): 5671-6, 1992 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1323718

RESUMEN

Using our previously described Haydée semipackaging cell line (F. L. Cosset, C. Legras, Y. Chebloune, P. Savatier, P. Thoraval, J. L. Thomas, J. Samarut, V. M. Nigon, and G. Verdier, J. Virol. 64:1070-1078, 1990) which produces avian leukosis virus gag and pol proteins, we have constructed packaging cells with subgroups B, C, and E envelope specificities. This allows us to produce helper-free avian leukosis virus particles carrying the lacZ reporter gene and the A, B, C, or E subgroup specificities. Titers of the recombinant lacZ virus are shown to be dependent upon the type of the env subgroup and the target avian cell.


Asunto(s)
Virus de la Leucosis Aviar/crecimiento & desarrollo , Virus de la Leucosis Aviar/genética , Línea Celular , Vectores Genéticos/genética , Plásmidos/genética , Animales , Aves/microbiología , Virus Helper , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/genética , Especificidad de la Especie , Transfección
4.
J Virol ; 65(10): 5374-80, 1991 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1654445

RESUMEN

The Rous-associated virus 1 env gene, which encodes the envelope gp85 and gp37 glycoproteins, was isolated and inserted in place of the v-erbB oncogene into an avian erythroblastosis virus-based vector, carrying the neo resistance gene substituted for the v-erbA oncogene, to generate the pNEA recombinant vector. A helper-free virus stock of the pNEA vector was produced on an avian transcomplementing cell line and used to infect primary chicken embryo fibroblasts (CEFs) or quail QT6 cells. These infected cells, selected with G418 (CEF/NEA and QT6/NEA, respectively) were found to be resistant to superinfections with subgroup A retroviruses. The CEF/NEA preparations were used as a cell-associated antigen to inoculate adult chickens by the intravenous route compared with direct inoculations of NEA recombinant helper-free virus used as a cell-free antigen. Chickens injected with the cell-associated antigen (CEF/NEA) exhibited an immune response demonstrated by induction of high titers of neutralizing antibodies and were found to be protected against tumor production after Rous sarcoma virus A challenge. Conversely, no immune response and no protection against Rous sarcoma virus A challenge were observed in chickens directly inoculated with cell-free NEA recombinant virus or in sham-inoculated chickens.


Asunto(s)
Alpharetrovirus/inmunología , Virus del Sarcoma Aviar/inmunología , Genes env , Vectores Genéticos , Glicoproteínas/inmunología , Sarcoma Aviar/inmunología , Alpharetrovirus/genética , Animales , Formación de Anticuerpos , Virus del Sarcoma Aviar/genética , Línea Celular , Células Cultivadas , Embrión de Pollo , Pollos , Coturnix , Cinética , Pruebas de Neutralización , Recombinación Genética , Mapeo Restrictivo , Factores de Tiempo , Virión/genética , Virión/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA